Advances in Microbiology, Infectious Diseases and Public Health: Volume 7: Advances in Experimental Medicine and Biology, cartea 973
Editat de Gianfranco Donellien Limba Engleză Hardback – 26 iun 2017
Din seria Advances in Experimental Medicine and Biology
- 70% Preț: 237.22 lei
- 5% Preț: 688.66 lei
- 5% Preț: 689.90 lei
- 15% Preț: 617.15 lei
- 5% Preț: 689.20 lei
- 5% Preț: 991.95 lei
- 5% Preț: 690.08 lei
- Preț: 642.95 lei
- 5% Preț: 239.86 lei
- 5% Preț: 820.42 lei
- 5% Preț: 688.32 lei
- 5% Preț: 1071.62 lei
- 15% Preț: 616.04 lei
- 5% Preț: 689.90 lei
- 5% Preț: 689.20 lei
- 20% Preț: 691.93 lei
- 20% Preț: 1117.65 lei
- 5% Preț: 1126.16 lei
- 18% Preț: 1077.43 lei
- 5% Preț: 1239.61 lei
- 5% Preț: 1120.53 lei
- 5% Preț: 1059.99 lei
- 18% Preț: 1081.06 lei
- 5% Preț: 1381.19 lei
- 20% Preț: 1004.51 lei
- 18% Preț: 910.53 lei
- 18% Preț: 252.54 lei
- 18% Preț: 921.32 lei
- 18% Preț: 1188.87 lei
- 5% Preț: 1184.85 lei
- 5% Preț: 395.78 lei
- 5% Preț: 1060.33 lei
- 18% Preț: 1089.86 lei
- 5% Preț: 1121.03 lei
- 5% Preț: 1364.67 lei
- 14% Preț: 1137.13 lei
- 18% Preț: 1363.93 lei
- 18% Preț: 1359.38 lei
- 24% Preț: 806.15 lei
- 18% Preț: 1196.13 lei
- 5% Preț: 1375.22 lei
- 5% Preț: 1557.29 lei
- 5% Preț: 1255.63 lei
- 18% Preț: 1082.26 lei
- 14% Preț: 955.92 lei
- 15% Preț: 625.30 lei
- 5% Preț: 1055.95 lei
- 18% Preț: 909.95 lei
Preț: 812.32 lei
Preț vechi: 855.08 lei
-5% Nou
Puncte Express: 1218
Preț estimativ în valută:
155.47€ • 164.01$ • 129.56£
155.47€ • 164.01$ • 129.56£
Carte tipărită la comandă
Livrare economică 02-16 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783319607641
ISBN-10: 3319607642
Pagini: 138
Ilustrații: VI, 138 p. 50 illus., 20 illus. in color.
Dimensiuni: 178 x 254 x 15 mm
Greutate: 0.48 kg
Ediția:1st ed. 2017
Editura: Springer International Publishing
Colecția Springer
Seriile Advances in Experimental Medicine and Biology, Advances in Microbiology, Infectious Diseases and Public Health
Locul publicării:Cham, Switzerland
ISBN-10: 3319607642
Pagini: 138
Ilustrații: VI, 138 p. 50 illus., 20 illus. in color.
Dimensiuni: 178 x 254 x 15 mm
Greutate: 0.48 kg
Ediția:1st ed. 2017
Editura: Springer International Publishing
Colecția Springer
Seriile Advances in Experimental Medicine and Biology, Advances in Microbiology, Infectious Diseases and Public Health
Locul publicării:Cham, Switzerland
Cuprins
Chapter 1: Selection of lactic acid bacteria with probiotic potential isolated from the fermentation process of "cupuaçu" (Theobroma grandiflorum).- Chapter 2: Effects of Fibronectin Coating on Bacterial and Osteoblast Progenitor Cells Adherence in a Co-culture Assay.- Chapter 3: Improving the Bacterial Recovery by Using Dithiothreitol with Aerobic and Anaerobic Broth in Biofilm-Related Prosthetic and Joint Infections.- Chapter 4: High Prevalence of Human Herpesvirus 8 Infection in Diabetes Type 2 Patients and Detection of a New Virus Subtype.- Chapter 5: Activity of Norspermidine on Bacterial Biofilms of Multidrug-Resistant Clinical Isolates Associated with Persistent Extremity Wound Infections.- Factors Affecting Outcome of Tuberculosis in Children in Italy: An Ecological Study.- Chapter 6: Factors Affecting Outcome of Tuberculosis in Children in Italy: An Ecological Study.- Chapter 7: Genotyping and antifungal susceptibility of Dipodascus capitatus isolated in a neonatal intensive care unit of a Sicilian Hospital.- Chapter 8: The correlation between biofilm production and catheter related blood stream infections sustained by Candida. A case control study.- Chapter 9: Inhibition of Urease enzyme production and some other virulence factors expression in Proteus mirabilis by N-acetyl cysteine and dipropyl disulphide.- Chapter 10: Immunization with Streptococcal Heme Binding Protein (Shp) Protects Mice against Group A Streptococcus Infection.- Chapter 11: The public health impact of the so-called "Fluad effect"on the 2014/2015 influenza vaccination campaign in Italy: ethical implications for health-care workers and health communication practitioners.
Textul de pe ultima copertă
This book series focuses on current progress in the broad field of medical microbiology, and covers both basic and applied topics related to the study of microbes, their interactions with human and animals, and emerging issues relevant for public health. Original research and review articles present and discuss multidisciplinary findings and developments on various aspects of microbiology, infectious diseases, and their diagnosis, treatment and prevention.
Advances in Microbiology, Infectious Diseases and Public Health is a subseries of Advances in Experimental Medicine and Biology, which has been publishing significant contributions in the field for over 30 years and is indexed in Medline, Scopus, EMBASE, BIOSIS, Biological Abstracts, CSA, Biological Sciences and Living Resources (ASFA-1), and Biological Sciences. 2015 Impact Factor: 1.953.
Advances in Microbiology, Infectious Diseases and Public Health is a subseries of Advances in Experimental Medicine and Biology, which has been publishing significant contributions in the field for over 30 years and is indexed in Medline, Scopus, EMBASE, BIOSIS, Biological Abstracts, CSA, Biological Sciences and Living Resources (ASFA-1), and Biological Sciences. 2015 Impact Factor: 1.953.
Caracteristici
t the clinical level Provides state-of-the-art information about infectious diseases affecting humans and animals Addresses the epidemiology and pathogenesis of emerging and re-emerging microbial infections Discusses the role of vaccines in the prophylaxis of severe infectious diseases Broadens the current understanding of multidrug-resistance and host immune response Informs on the new strategies for treatment of acute and chronic microbial infections Promotes prompt validation and transfer of the most promising experimental results a
Notă biografică
Gianfranco Donelli obtained his master degree in Biological Sciences from the Sapienza University of Rome in 1966. From 1967 onwards he worked as researcher at the Istituto Superiore di Sanità (ISS - Italian National Institute of Health) in Rome in the field of molecular biology and ultrastructure of bacteriophages and human intestinal viruses. In 1975 he was appointed Director of the Electron Microscopy Unit and in 1979 he became the Research Director in molecular biology. In 1982 he founded the Laboratory of Ultrastructures of ISS that has been led by him till 1996. In those years his main research interests covered many aspects of cellular microbiology with special reference to the mechanism of action and the pathogenetic role of toxins and other bacterial virulence factors. He has been invited since 1977 to serve as visiting professor in the Universities of Ancona, Naples, Perugia, Rome and Urbino and in 1999, he was habilitated as full Professor of Microbiology.
Regarding his scientific assignments, Professor Donelli has been appointed Coordinator of the Infectious Diseases Research Project of ISS (1991–1995); Vice-President of the Advisory Committee for Biological and Medical Sciences of the Italian National Research Council (1994–1999); International Affairs Officer of the Italian Society of Microbiology and FEMS delegate (2002–2022); President of the Society for Microbial Ecology and Disease (2006–2009),Vice-Chairperson of the Executive Committee of ESCMID Study Group for Biofilms (2009–2013) and Director of the Microbial Biofilm Laboratory at the Fondazione Santa Lucia research hospital in Rome (2000–2022). In the last two decades, his research activity has been mainly focused on biofilm-based healthcare-associated infections and the possible strategies to prevent and counteract the development of microbial biofilms in the human body.
Professor Donelli is in the list of the Top Italian Scientists in Biomedical Sciences as author of over 210 full-length papers published in international journals (H-index = 60) with more than 13350 citations, and editor of a number of books.
Regarding his scientific assignments, Professor Donelli has been appointed Coordinator of the Infectious Diseases Research Project of ISS (1991–1995); Vice-President of the Advisory Committee for Biological and Medical Sciences of the Italian National Research Council (1994–1999); International Affairs Officer of the Italian Society of Microbiology and FEMS delegate (2002–2022); President of the Society for Microbial Ecology and Disease (2006–2009),Vice-Chairperson of the Executive Committee of ESCMID Study Group for Biofilms (2009–2013) and Director of the Microbial Biofilm Laboratory at the Fondazione Santa Lucia research hospital in Rome (2000–2022). In the last two decades, his research activity has been mainly focused on biofilm-based healthcare-associated infections and the possible strategies to prevent and counteract the development of microbial biofilms in the human body.
Professor Donelli is in the list of the Top Italian Scientists in Biomedical Sciences as author of over 210 full-length papers published in international journals (H-index = 60) with more than 13350 citations, and editor of a number of books.